Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations

Spanidis,Ypatios; Mpesios,Anastasios; Stagos,Dimitrios; Goutzourelas,Nikolaos; Bar‑Or,David; Karapetsa,Maria; Zakynthinos,Epaminondas; Spandidos,Demetrios A.; Tsatsakis,Aristides   M.; Leon,George; Kouretas,Demetrios

doi:10.3892/etm.2016.2968

Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations

Authors:
- Ypatios Spanidis
- Anastasios Mpesios
- Dimitrios Stagos
- Nikolaos Goutzourelas
- David Bar‑Or
- Maria Karapetsa
- Epaminondas Zakynthinos
- Demetrios A. Spandidos
- Aristides M. Tsatsakis
- George Leon
- Demetrios Kouretas
View Affiliations

Affiliations: Department of Biochemistry and Biotechnology, University of Thessaly, Larissa 41221, Greece, Department of Trauma Research, St. Anthony Hospital, Lakewood, CO 80228, USA, Department of Intensive Care, University Hospital of Thessaly Biopolis, Larissa 41110, Greece, Laboratory of Clinical Virology, University of Crete, Medical School, Heraklion 71409, Greece, Department of Forensic Sciences and Toxicology, Medical School, University of Crete, Heraklion 71003, Greece, Standard Centre of Bioassays, ‘Hartografoi Hygeias’, Athens 15124, Greece
Published online on: January 5, 2016 https://doi.org/10.3892/etm.2016.2968
Pages: 895-903
Copyright: © Spanidis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the effectiveness of a new redox status marker, the static oxidation reduction potential (sORP), for assessing oxidative stress in 75 patients with metabolic syndrome (MetS) and type 2 diabetes (T2D). A total of 35 normal subjects were used as the controls. Moreover, conventional markers of oxidative stress were assessed, such as thiobarbituric acid reactive substances (TBARS), protein carbonyls, the total antioxidant capacity in plasma, glutathione (GSH) levels and catalase (CAT) activity in erythrocytes. The results revealed that sORP was significantly higher (by 13.4%) in the patients with MetS and T2D compared to the controls, indicating an increase in oxidative stress. This finding was also supported by the significantly lower levels (by 27.7%) of GSH and the higher levels (by 23.3%) of CAT activity in the patients with MetS and T2D compared to the controls. Moreover, our results indicated a great variation in oxidative stress markers between the different patients with MetS and T2D, particarly as regards the GSH levels. Thus, the patients with MetS and T2D were divided into 2 subgroups, one with low GSH levels (n=31; GSH <3 µmol/g Hb) and another with high GSH levels (n=35; GSH >4 µmol/g Hb). The comparison of the markers between the 2 subgroups indicated that in the low GSH group, the GSH levels were significantly lower (by 51.7 and 52.9%) than those in the high GSH group and the controls, respectively. Furthermore, sORP in the low GSH group was significantly higher (by 8.1%) compared to the high GSH group, suggesting its sensitivity for assessing oxidative stress in patients wtih MetS and T2D. Moreover, this variation in oxidative stress levels between the different patients with T2D suggests that the assessment of the redox status may be important in prediabetic conditions, since there is evidence indicating that differences in the redox status in pre-diabetes may result in different outcomes.

View Figures

View References

1	Halliwell B: The wanderings of a free radical. Free Radic Biol Med. 46:531–542. 2009. View Article : Google Scholar : PubMed/NCBI
2	Ghosh J and Myers CE: Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA. 95:13182–13187. 1998. View Article : Google Scholar : PubMed/NCBI
3	Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI
4	Orient A, Donkó A, Szabó A, Leto TL and Geiszt M: Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant. 22:1281–1288. 2007. View Article : Google Scholar : PubMed/NCBI
5	Mylonas C and Kouretas D: Lipid peroxidation and tissue damage. In Vivo. 13:295–309. 1999.PubMed/NCBI
6	Ford ES, Mokdad AH, Giles WH and Brown DW: The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 52:2346–2352. 2003. View Article : Google Scholar : PubMed/NCBI
7	Jahan-Mihan A, Rodriguez J, Christie C, Sadeghi M and Zerbe T: The Role of Maternal Dietary Proteins in Development of Metabolic Syndrome in Offspring. Nutrients. 7:9185–9217. 2015. View Article : Google Scholar : PubMed/NCBI
8	Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352:1685–1695. 2005. View Article : Google Scholar : PubMed/NCBI
9	Schleicher E, Weigert C, Rohrbach H, Nerlich A, Bachmeier B and Friess U: Role of glucoxidation and lipid oxidation in the development of atherosclerosis. Ann N Y Acad Sci. 1043:343–354. 2005. View Article : Google Scholar : PubMed/NCBI
10	Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, et al: Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 88:4673–4676. 2003. View Article : Google Scholar : PubMed/NCBI
11	Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Yano Y and Adachi Y: Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care. 27:631–632. 2004. View Article : Google Scholar : PubMed/NCBI
12	Nikooyeh B and Neyestani TR: Oxidative stress, type 2 diabetes and vitamin D: Past, present and future. Diabetes Metab Res Rev: Sep. 26:2015(Epub ahead of print).
13	Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res. 107:1058–1070. 2010. View Article : Google Scholar : PubMed/NCBI
14	Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C and Muscogiuri G: The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. 7:313–324. 2011. View Article : Google Scholar : PubMed/NCBI
15	Ha CY, Kim JY, Paik JK, Kim OY, Paik Y-H, Lee EJ and Lee JH: The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf). 76:674–682. 2012. View Article : Google Scholar : PubMed/NCBI
16	Yorek MA: The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res. 37:471–480. 2003. View Article : Google Scholar : PubMed/NCBI
17	Aroor AR and DeMarco VG: Oxidative stress and obesity: the chicken or the egg? Diabetes. 63:2216–2218. 2014. View Article : Google Scholar : PubMed/NCBI
18	Dalle-Donne I, Rossi R, Colombo R, Giustarini D and Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem. 52:601–623. 2006. View Article : Google Scholar : PubMed/NCBI
19	Ogino K and Wang DH: Biomarkers of oxidative/nitrosative stress: An approach to disease prevention. Acta Med Okayama. 61:181–189. 2007.PubMed/NCBI
20	Stagos D, Goutzourelas N, Bar-Or D, Ntontou AM, Bella E, Becker AT, Statiri A, Kafantaris I and Kouretas D: Application of a new oxidation-reduction potential assessment method in strenuous exercise-induced oxidative stress. Redox Rep. 20:154–162. 2015. View Article : Google Scholar : PubMed/NCBI
21	Stagos D, Goutzourelas N, Ntontou AM, Kafantaris I, Deli CK, Poulios A, Jamurtas AZ, Bar-Or D and Kouretas D: Assessment of eccentric exercise-induced oxidative stress using oxidation-reduction potential markers. Oxid Med Cell Longev. 2015:2046152015. View Article : Google Scholar : PubMed/NCBI
22	Spanidis Y, Goutzourelas N, Stagos D, Kolyva AS, Gogos CA, Bar-Or D and Kouretas D: Assessment of oxidative stress in septic and obese patients using markers of oxidation-reduction potential. In Vivo. 29:595–600. 2015.PubMed/NCBI
23	Spanidis Y, Goutzourelas N, Stagos D, Mpesios A, Priftis A, Bar-Or D, Spandidos DA, Tsatsakis AM, Leon G and Kouretas D: Variations in oxidative stress markers in elite basketball players at the beginning and end of a season. Exp Ther Med. 11:147–153. 2016.PubMed/NCBI
24	Keles MS, Taysi S, Sen N, Aksoy H and Akçay F: Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis. Can J Neurol Sci. 28:141–143. 2001.PubMed/NCBI
25	Patsoukis N, Zervoudakis G, Panagopoulos NT, Georgiou CD, Angelatou F and Matsokis NA: Thiol redox state (TRS) and oxidative stress in the mouse hippocampus after pentylenetetrazol-induced epileptic seizure. Neurosci Lett. 357:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
26	Reddy YN, Murthy SV, Krishna DR and Prabhakar MC: Role of free radicals and antioxidants in tuberculosis patients. Indian J Tuberc. 51:213–218. 2004.
27	Aebi H: Catalase in vitro. Methods Enzymol. 105:121–126. 1984. View Article : Google Scholar : PubMed/NCBI
28	Janaszewska A and Bartosz G: Assay of total antioxidant capacity: Comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest. 62:231–236. 2002. View Article : Google Scholar : PubMed/NCBI
29	Bloomer RJ and Fisher-Wellman KH: Blood oxidative stress biomarkers: influence of sex, exercise training status, and dietary intake. Gend Med. 5:218–228. 2008. View Article : Google Scholar : PubMed/NCBI
30	Ristoff E and Larsson A: Oxidative stress in inborn errors of metabolism: lessons from glutathione deficiency. J Inherit Metab Dis. 25:223–226. 2002. View Article : Google Scholar : PubMed/NCBI
31	Wilson PWF and Grundy SM: The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation. 108:1422–1424. 2003. View Article : Google Scholar : PubMed/NCBI
32	Balkau B, Charles MA, Drivsholm T, et al: European Group For The Study Of Insulin Resistance (EGIR): Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 28:364–376. 2002.PubMed/NCBI
33	Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M and Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 114:1752–1761. 2004. View Article : Google Scholar : PubMed/NCBI
34	Roberts CK and Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci. 84:705–712. 2009. View Article : Google Scholar : PubMed/NCBI
35	Ceriello A and Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 24:816–823. 2004. View Article : Google Scholar : PubMed/NCBI
36	Armutcu F, Ataymen M, Atmaca H and Gurel A: Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem Lab Med. 46:785–790. 2008. View Article : Google Scholar : PubMed/NCBI
37	Akbar S, Bellary S and Griffiths HR: Dietary antioxidant interventions in type 2 diabetes patients: A meta-analysis. Br J Diabetes Vasc Dis. 11:62–68. 2011. View Article : Google Scholar
38	Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A and Khalaji N: Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: A possible role in the prevention of long-term complications. J Endocrinol Invest. 30:833–838. 2007. View Article : Google Scholar : PubMed/NCBI
39	Neyestani TR, Shariat-Zadeh N, Gharavi A, Kalayi A and Khalaji N: The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: A possible role in atherogenesis. Iran J Allergy Asthma Immunol. 6:79–87. 2007.PubMed/NCBI
40	Vávrová L, Kodydková J, Zeman M, Dušejovská M, Macášek J, Staňková B, Tvrzická E and Zák A: Altered activities of antioxidant enzymes in patients with metabolic syndrome. Obes Facts. 6:39–47. 2013. View Article : Google Scholar : PubMed/NCBI
41	Hakki Kalkan I and Suher M: The relationship between the level of glutathione, impairment of glucose metabolism and complications of diabetes mellitus. Pak J Med Sci. 29:938–942. 2013.PubMed/NCBI
42	Seghrouchni I, Drai J, Bannier E, Rivière J, Calmard P, Garcia I, Orgiazzi J and Revol A: Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta. 321:89–96. 2002. View Article : Google Scholar : PubMed/NCBI
43	Ciuchi E, Odetti P and Prando R: Relationship between glutathione and sorbitol concentrations in erythrocytes from diabetic patients. Metabolism. 45:611–613. 1996. View Article : Google Scholar : PubMed/NCBI
44	Mazzetti AP, Fiorile MC, Primavera A and Lo Bello M: Glutathione transferases and neurodegenerative diseases. Neurochem Int. 82:10–18. 2015. View Article : Google Scholar : PubMed/NCBI
45	Pérez S, Pereda J, Sabater L and Sastre J: Redox signaling in acute pancreatitis. Redox Biol. 5:1–14. 2015. View Article : Google Scholar : PubMed/NCBI
46	Lee AY and Chung SS: Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 13:23–30. 1999.PubMed/NCBI
47	Góth L: Reactive oxygen species, hydrogen peroxide, catalase and diabetes mellitus. Redox Rep. 11:281–282. 2006. View Article : Google Scholar : PubMed/NCBI
48	Weidig P, McMaster D and Bayraktutan U: High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes Metab. 6:432–441. 2004. View Article : Google Scholar : PubMed/NCBI
49	Manea A, Constantinescu E, Popov D and Raicu M: Changes in oxidative balance in rat pericytes exposed to diabetic conditions. J Cell Mol Med. 8:117–126. 2004. View Article : Google Scholar : PubMed/NCBI
50	Tiedge M, Lortz S, Drinkgern J and Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 46:1733–1742. 1997. View Article : Google Scholar : PubMed/NCBI
51	Venturini D, Simão ANC and Dichi I: Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation. Nutr Res. 35:759–765. 2015. View Article : Google Scholar : PubMed/NCBI
52	Sohet FM, Neyrinck AM, Dewulf EM, Bindels LB, Portois L, Malaisse WJ, Carpentier YA, Cani PD and Delzenne NM: Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice. Br J Nutr. 102:462–469. 2009. View Article : Google Scholar : PubMed/NCBI
53	Tabak O, Gelisgen R, Erman H, Erdenen F, Muderrisoglu C, Aral H and Uzun H: Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med. 34:E163–E171. 2011.PubMed/NCBI
54	Cakatay U: Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab. 31:551–557. 2005. View Article : Google Scholar : PubMed/NCBI
55	Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P and Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1304–1313. 1996. View Article : Google Scholar : PubMed/NCBI
56	Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM, Frascerra S, Ciociaro D and Ferrannini E: Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 9:746–752. 1996. View Article : Google Scholar : PubMed/NCBI
57	Watson JD: Type 2 diabetes as a redox disease. Lancet. 383:841–843. 2014. View Article : Google Scholar : PubMed/NCBI
58	Sharoff CG, Hagobian TA, Malin SK, Chipkin SR, Yu H, Hirshman MF, Goodyear LJ and Braun B: Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. Am J Physiol Endocrinol Metab. 298:E815–E823. 2010. View Article : Google Scholar : PubMed/NCBI
59	Ron D and Harding HP: Protein-folding homeostasis in the endoplasmic reticulum and nutritional regulation. Cold Spring Harb Perspect Biol. 4:42012. View Article : Google Scholar
60	Nardai G, Stadler K, Papp E, Korcsmáros T, Jakus J and Csermely P: Diabetic changes in the redox status of the microsomal protein folding machinery. Biochem Biophys Res Commun. 334:787–795. 2005. View Article : Google Scholar : PubMed/NCBI
61	Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR and Blüher M: Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA. 106:8665–8670. 2009. View Article : Google Scholar : PubMed/NCBI
62	Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, et al: Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest. 120:4220–4235. 2010. View Article : Google Scholar : PubMed/NCBI